Status:
COMPLETED
Optimizing Viral Load Suppression in Kenyan Children on Antiretroviral Therapy
Lead Sponsor:
University of Alabama at Birmingham
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Kenya Medical Research Institute
Conditions:
Chronic HIV Infection
Eligibility:
All Genders
1-14 years
Phase:
NA
Brief Summary
Among nearly 1 million HIV-infected children receiving antiretroviral treatment (ART), as many as 40% of those living in resource limited settings have not achieved virologic suppression. Kenya, a The...
Detailed Description
The study design will be a randomized, controlled study to pilot the use of POC VL and DRM testing in children aged 1-14 years on first-line ART. Children enrolling at each site will be randomized 1:1...
Eligibility Criteria
Inclusion
- Children aged 1-14 years living with HIV (documented HIV positive)
- On first-line ART per Kenyan National Guideline or
- Newly initiating ART
Exclusion
- On second-line, third-line, or non-standard first-line ART
Key Trial Info
Start Date :
March 7 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
704 Patients enrolled
Trial Details
Trial ID
NCT03820323
Start Date
March 7 2019
End Date
December 31 2020
Last Update
April 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rtcp-Faces
Kisumu, Kenya